Actively Recruiting
Transcranial Pulse Stimulation (TPS) in Post-COVID-19
Led by Medical University of Vienna · Updated on 2025-12-23
102
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue, cognitive deficits, mood deterioration). Fatigue, as measured by the Fatigue Impact Scale (FIS), will represent the primary outcome variable. The verum treatment will be compared to a sham (placebo) condition.
CONDITIONS
Official Title
Transcranial Pulse Stimulation (TPS) in Post-COVID-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed written informed consent
- Confirmed COVID-19 infection by PCR, antibody test, or physician diagnosis
- At least 12 months since initial COVID-19 infection causing Post-COVID symptoms
- Diagnosis or suspected diagnosis of Post-COVID Syndrome by a physician
- Age between 20 and 80 years
- Negative pregnancy test if applicable
You will not qualify if you...
- History of pre-COVID diseases causing symptoms similar to Post-COVID
- MoCA score below 17 indicating dementia
- BDI-II score 29 or higher indicating severe depression
- Fatigue Impact Scale score below 10 indicating no fatigue
- Presence of brain implants or metal parts in the head
- Use of anticoagulant medications
- Claustrophobia incompatible with MRI
- Presence of pacemaker
- Pregnant or breastfeeding women
- History of relevant surgery on head, heart, or vessels
- Recent corticosteroid treatments within 6 weeks prior to study
- Tumors in the head affecting treatment
- Blood clotting disorders
- Participation in other clinical studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Vienna
Vienna, State of Vienna, Austria, 1090
Actively Recruiting
Research Team
R
Roland Beisteiner, Prof.
CONTACT
M
Michael Mitterwallner, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here